Chengda Biotech eyes listing in Hong Kong
Liaoning Chengda Biotechnology filed for a Hong Kong flotation on Tuesday through sponsors CLSA and GF Capital.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: